The National Agency for Food and Drug Administration and Control (NAFDAC) has warned Nigerians against the marketing, sale and use of an unregistered product identified as Menofix Capsules, citing concerns over its regulatory status and possible health risks.
In Public Alert No. 035/2026, the agency disclosed that it received a complaint regarding the sale of the product, alongside reports of possible liver-related adverse effects linked to some of its ingredients.
Following an investigation, NAFDAC confirmed that Menofix Capsules, marketed by PureEve, is not registered with the agency and is therefore not authorised for distribution or sale in Nigeria.
The agency explained that the unregistered product is different from two similarly named products that have valid NAFDAC registration. These are Menofix Herbal Capsule (NAFDAC Registration No. A7-103321L) and Menofix Powder (NAFDAC Registration No. A7-103342L), both registered as herbal and nutraceutical products and manufactured by Gudugudu Herbal Worldwide Enterprises.
According to NAFDAC, the unregistered Menofix Capsules is promoted as a hormone-free, vegetarian-friendly multivitamin and herbal supplement intended to help women manage the physical and hormonal changes associated with perimenopause and menopause.
The agency noted that the product appears to be widely available over the counter through online platforms and retail outlets despite lacking regulatory approval.
As part of enforcement measures, NAFDAC said it has launched surveillance operations to trace the product’s distribution network, while all zonal directors and state coordinators have been directed to intensify market surveillance and immediately seize the unregistered product wherever it is found.
The agency urged healthcare professionals, medicine vendors and members of the public to remain vigilant and avoid purchasing or using unregistered medical products, warning that such products may pose serious risks to public health.
NAFDAC also appealed to Nigerians to report any suspected sale or distribution of substandard, falsified or unregistered medicines and medical devices to the nearest NAFDAC office, through its toll-free line 0800-162-3322, or via email at sf.alert@nafdac.gov.ng.
The agency reiterated its commitment to safeguarding public health through strict regulatory oversight and enforcement against the circulation of unregistered pharmaceutical and healthcare products in the country.
